BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 16026307)

  • 1. Therapeutic potential of the endocannabinoid system in the brain.
    Ramos JA; González S; Sagredo O; Gómez-Ruiz M; Fernández-Ruiz J
    Mini Rev Med Chem; 2005 Jul; 5(7):609-17. PubMed ID: 16026307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview on the biochemistry of the cannabinoid system.
    Gómez-Ruiz M; Hernández M; de Miguel R; Ramos JA
    Mol Neurobiol; 2007 Aug; 36(1):3-14. PubMed ID: 17952645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endocannabinoid system and pain.
    Guindon J; Hohmann AG
    CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):403-21. PubMed ID: 19839937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.
    Lambert DM; Fowler CJ
    J Med Chem; 2005 Aug; 48(16):5059-87. PubMed ID: 16078824
    [No Abstract]   [Full Text] [Related]  

  • 5. Endocannabinoid System: A Multi-Facet Therapeutic Target.
    Kaur R; Ambwani SR; Singh S
    Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endocannabinoid system: physiology and pharmacology.
    Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
    Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
    Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
    Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytocannabinoids and endocannabinoids.
    Fisar Z
    Curr Drug Abuse Rev; 2009 Jan; 2(1):51-75. PubMed ID: 19630737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.
    Snider NT; Walker VJ; Hollenberg PF
    Pharmacol Rev; 2010 Mar; 62(1):136-54. PubMed ID: 20133390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology.
    Giuffrida A; Beltramo M; Piomelli D
    J Pharmacol Exp Ther; 2001 Jul; 298(1):7-14. PubMed ID: 11408519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors.
    Minkkilä A; Saario S; Nevalainen T
    Curr Top Med Chem; 2010; 10(8):828-58. PubMed ID: 20370710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid/Endocannabinoid signaling impact on early pregnancy events.
    Sun X; Dey SK
    Curr Top Behav Neurosci; 2009; 1():255-73. PubMed ID: 21104387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychopharmacology of the endocannabinoids: far beyond anandamide.
    Pamplona FA; Takahashi RN
    J Psychopharmacol; 2012 Jan; 26(1):7-22. PubMed ID: 21652605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuropharmacology of cannabinoid receptor ligands in central signaling pathways.
    Brunt TM; Bossong MG
    Eur J Neurosci; 2022 Feb; 55(4):909-921. PubMed ID: 32974975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?].
    Saito VM; Wotjak CT; Moreira FA
    Braz J Psychiatry; 2010 May; 32 Suppl 1():S7-14. PubMed ID: 20512266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel natural and synthetic ligands of the endocannabinoid system.
    Hanus LO; Mechoulam R
    Curr Med Chem; 2010; 17(14):1341-59. PubMed ID: 20166928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study.
    Romero J; Hillard CJ; Calero M; Rábano A
    Brain Res Mol Brain Res; 2002 Apr; 100(1-2):85-93. PubMed ID: 12008024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids and the gut: new developments and emerging concepts.
    Izzo AA; Sharkey KA
    Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids biology: the search for new therapeutic targets.
    Felder CC; Dickason-Chesterfield AK; Moore SA
    Mol Interv; 2006 Jun; 6(3):149-61. PubMed ID: 16809476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system.
    Gertsch J
    Planta Med; 2008 May; 74(6):638-50. PubMed ID: 18275004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.